BAN2802 / BioArctic, Eisai - LARVOL DELTA

BioArctic and Eisai sign research evaluation agreement regarding BAN2802 (PRNewswire) - "BioArctic AB...today announced that BioArctic AB and Eisai Co., Ltd., have entered into a research evaluation agreement regarding BAN2802....At the end of the collaboration, Eisai will evaluate the data generated and decide if they chose to exercise an option to license BAN2802 for the treatment of Alzheimer's disease."

Licensing / partnership • Alzheimer's Disease • CNS Disorders